Bank of Montreal’s Autolus Therapeutics AUTL Stock Holding History

Bank of Montreal’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-145	Closed	-$1K	–	3735
2021 Q1	$1K	Buy	+145	New	+$1.07K	﹤0.01%	4960
2020 Q1	–	Sell	-12,000	Closed	-$158K	–	4095
2019 Q4	$158K	Hold	12,000	–	–	﹤0.01%	3279
2019 Q3	$149K	Hold	12,000	–	–	﹤0.01%	3085
2019 Q2	$193K	Hold	12,000	–	–	﹤0.01%	2941
2019 Q1	$378K	Hold	12,000	–	–	﹤0.01%	2422
2018 Q4	$394K	Sell	12,000 -4,000	-25%	-$132K	﹤0.01%	2265
2018 Q3	$491K	Hold	16,000	–	–	﹤0.01%	2341
2018 Q2	$429K	Buy	+16,000	New	+$423K	﹤0.01%	2403

Other funds holding AUTL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's AUTL Position: Q2 2021 in Review

Bank of Montreal sold out of Autolus Therapeutics (AUTL) in Q2 2021, closing a stake of 145 shares — an estimated $1K sold.

Bank of Montreal first reported a position in AUTL in Q2 2018 and held it in 8 quarters. The position peaked at $491K in Q3 2018. 69 funds tracked by Wall St. Rank hold AUTL as of Q2 2021.

Bank of Montreal reported no remaining Autolus Therapeutics position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 145 Autolus Therapeutics shares in Q2 2021, an estimated $1K.
Bank of Montreal first reported a position in Autolus Therapeutics in Q2 2018 and held it in 8 quarters.
Bank of Montreal's Autolus Therapeutics position peaked at $491K in Q3 2018.
69 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.